Option Care Health (OPCH)
(Delayed Data from NSDQ)
$28.26 USD
-1.09 (-3.71%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $28.26 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth C Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OPCH 28.26 -1.09(-3.71%)
Will OPCH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OPCH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OPCH
Option Care (OPCH) Surpasses Q2 Earnings and Revenue Estimates
BTSG vs. OPCH: Which Home Infusion Stock is a Better Buy Now?
OPCH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Can BrightSpring's Q1 Strength Carry Through 2025 Headwinds?
BrightSpring Soars to All-Time High on Quality Strength: Still a Buy?
Option Care (OPCH) is an Incredible Growth Stock: 3 Reasons Why
Other News for OPCH
OPCH Sees Price Target Increase from JMP Securities | OPCH Stock News
Option Care Health (OPCH) Sees Price Target Increase After Strong Q2
Option Care Health price target raised by $2 at Citizens JMP, here's why
Option Care Health Inc (OPCH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ...
Option Care Health raises 2025 revenue guidance to $5.65B while expanding infusion suite efficiency